Loading viewer...
investor_presentation
Format: PDF investor_presentation
TELOMERE TARGETING IMMUNOTHERAPIES FOR CANCER NYSE AMERICAN: MAIA October 2022
TELOMERE TARGETING IMMUNOTHERAPIES FOR CANCER
All statements in this presentation, other than those relating to historical facts, are "forward -looking statements." These forw ard-looking statements may include, but are not limited to, statements relating to
our objectives, plans, and strategies; statements that contain projections of results of operations or of financial condition ; statements relating to the industry and government policies and regulations relating to
our industry; and all statements (other than statements of historical facts) that address activities, events, or developments that we intend, expect, project, believe, or anticipate will or may occur in the future.
Forward -looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based th ese forward -looking statements on assumptions and assessments made by our
management in light of their experience and their perception of historical trends, current conditions, expected future develo pme nts, and other factors they believe to be appropriate. Important factors that
could cause actual results, developments, and business decisions to differ materially from those anticipated in these forward -looking statements include, among other things: the overall global economic
environment; general market, political, and economic conditions in the countries in which we operate: projected capital expen ditures and liquidity; changes in our strategy; government regulations and
approvals; the application of certain service license; and litigation and regulatory proceedings. Additional factors that co uldcause or contribute to differences between the Company's actual results and forward -
looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities a nd Exchange Commission (the “SEC”), including, but not limited to, the risks detailed in
the Company’s registration statement on Form S -1, as amended (Registration No.: 333 -264225), and any subsequent filings with the SEC. You may get these documents for free by visiting EDGAR on the
Commission's website at www.sec.gov. We caution you that forward -looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and
the development of the industry in which we operate may differ materially from the forward looking statements contained in th is presentation as a result of, among other factors, the factors referenced in the
"Risk Factors” section of the Registration Statement. In addition, even if our results of operations, financial condition and liquidity, and the development of the industry in which we operate are consistent with
investor_presentation
Downer EDI Limited
Trendlines Group 2018 Investor Presentation
investor_presentationinvestor_presentation
28 Pages
The Trendlines Group Ltd
the forward -looking statements contained in this presentation, they may not be predictive of results or developments in future p eriods. These statements are only current predictions and are subject to known
Preview truncated — download the full document for the complete content.
investor_presentation
4D Pharma